Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices

Alaide Chieffo*, Dariusz Dudek, Christian Hassager, Alain Combes, Mario Gramegna, Sigrun Halvorsen, Kurt Huber, Vijay Kunadian, Jiri Maly, Jacob Eifer Møller, Federico Pappalardo, Giuseppe Tarantini, Guido Tavazzi, Holger Thiele, Christophe Vandenbriele, Nicolas Van Mieghem, Pascal Vranckx, Nikos Werner, Susanna Price

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

18 Citations (Scopus)


There has been a significant increase in the use of short-term percutaneous ventricular assist devices (pVADs) as acute circulatory support in cardiogenic shock and to provide haemodynamic support during interventional procedures, including high-risk percutaneous coronary interventions. Although frequently considered together, pVADs differ in their haemodynamic effects, management, indications, insertion techniques, and monitoring requirements. This consensus document summarizes the views of an expert panel by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the Association for Acute Cardiovascular Care (ACVC) and appraises the value of short-term pVAD. It reviews the pathophysiological context and possible indications for pVAD in different clinical settings and provides guidance regarding the management of pVAD based on existing evidence and best current practice.

Original languageEnglish
Pages (from-to)E274-E286
Issue number4
Publication statusPublished - Jul 2021

Bibliographical note

Conflict of interest: A.C. received consulting fees/honoraria from Abiomed, Abbott Vascular, Cardinal Health, Biosensor, Magenta Medical. D.D. has served on the Scientific Advisory Board of Impella CP. A.C. received grants and personal fees from Getinge. J.E.M. received grants and personal fees from Abiomed and personal fees from Orion Pharma and Novartis. F.P. received personal fees from Abiomed. G.T. received personal fees from Abiomed and GADA. G.T. received personal fees from GE Healthcare. N.v.M. received grants and personal fees from Abbott Vascular, Medtronic, Boston Scientific, PulseCath BV. N.W. received personal fees and non-financial support from Abiomed. None of the other Authors has relevant conflicts of interest to disclose.
Publisher Copyright:
© Europa Digital & Publishing 2021. All rights reserved.


Dive into the research topics of 'Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices'. Together they form a unique fingerprint.

Cite this